Rench Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-88,034
| Closed | -$2.53M | – | 55 |
|
|
2023
Q4 | $2.53M | Sell |
88,034
-15,029
| -15% | -$454K | 1.07% | 36 |
|
|
2023
Q3 | $3.42M | Sell |
103,063
-4,002
| -4% | -$142K | 1.57% | 32 |
|
|
2023
Q2 | $3.93M | Buy |
107,065
+908
| +0.9% | +$35.3K | 1.72% | 29 |
|
|
2023
Q1 | $4.33M | Sell |
106,157
-5,120
| -5% | -$221K | 2.07% | 21 |
|
|
2022
Q4 | $5.7M | Buy |
111,277
+785
| +0.7% | +$37.6K | 2.9% | 13 |
|
|
2022
Q3 | $4.83M | Buy |
110,492
+479
| +0.4% | +$23.3K | 2.71% | 13 |
|
|
2022
Q2 | $5.77M | Sell |
110,013
-198
| -0.2% | -$10.1K | 2.96% | 11 |
|
|
2022
Q1 | $5.71M | Sell |
110,211
-12,912
| -10% | -$670K | 2.59% | 13 |
|
|
2021
Q4 | $7.27M | Sell |
123,123
-910
| -0.7% | -$45.1K | 3.28% | 13 |
|
|
2021
Q3 | $5.33M | Buy |
124,033
+63
| +0.1% | +$2.79K | 2.65% | 17 |
|
|
2021
Q2 | $4.86M | Buy |
123,970
+5,162
| +4% | +$201K | 2.42% | 20 |
|
|
2021
Q1 | $4.3M | Buy |
118,808
+7,297
| +7% | +$259K | 2.24% | 21 |
|
|
2020
Q4 | $4.11M | Buy |
111,511
+3,215
| +3% | +$118K | 2.31% | 21 |
|
|
2020
Q3 | $3.77M | Buy |
108,296
+16,322
| +18% | +$572K | 2.4% | 21 |
|
|
2020
Q2 | $2.85M | Buy |
91,974
+4,294
| +5% | +$146K | 1.92% | 22 |
|
|
2020
Q1 | $2.71M | Buy |
87,680
+5,026
| +6% | +$171K | 2.11% | 21 |
|
|
2019
Q4 | $3.07M | Buy |
82,654
+3,999
| +5% | +$142K | 1.77% | 28 |
|
|
2019
Q3 | $2.68M | Buy |
78,655
+3,452
| +5% | +$126K | 1.73% | 32 |
|
|
2019
Q2 | $3.09M | Sell |
75,203
-160
| -0.2% | -$6.35K | 1.98% | 26 |
|
|
2019
Q1 | $3.04M | Buy |
75,363
+197
| +0.3% | +$7.89K | 1.99% | 24 |
|
|
2018
Q4 | $3.11M | Buy |
75,166
+773
| +1% | +$32.1K | 2.28% | 19 |
|
|
2018
Q3 | $3.11M | Sell |
74,393
-1,099
| -1% | -$42.3K | 2.07% | 23 |
|
|
2018
Q2 | $2.6M | Sell |
75,492
-1,308
| -2% | -$44.7K | 1.88% | 25 |
|
|
2018
Q1 | $2.59M | Sell |
76,800
-1,468
| -2% | -$50.5K | 1.77% | 27 |
|
|
2017
Q4 | $2.69M | Sell |
78,268
-1,699
| -2% | -$57.9K | 1.75% | 28 |
|
|
2017
Q3 | $2.71M | Sell |
79,967
-5,181
| -6% | -$167K | 1.87% | 26 |
|
|
2017
Q2 | $2.71M | Buy |
85,148
+390
| +0.5% | +$12.3K | 2.01% | 25 |
|
|
2017
Q1 | $2.75M | Buy |
84,758
+4,883
| +6% | +$154K | 2.04% | 26 |
|
|
2016
Q4 | $2.46M | Buy |
79,875
+7,645
| +11% | +$233K | 1.95% | 24 |
|
|
2016
Q3 | $2.32M | Buy |
+72,230
| New | +$2.42M | 1.87% | 25 |
|
|
2015
Q4 | – | Sell |
-7,373
| Closed | -$220K | – | 42 |
|
|
2015
Q3 | $220K | Sell |
7,373
-130
| -2% | -$4.17K | 0.2% | 40 |
|
|
2015
Q2 | $239K | Sell |
7,503
-1,189
| -14% | -$38.8K | 0.21% | 40 |
|
|
2015
Q1 | $287K | Buy |
8,692
+69
| +0.8% | +$2.19K | 0.25% | 42 |
|
|
2014
Q4 | $255K | Sell |
8,623
-527
| -6% | -$15.1K | 0.21% | 42 |
|
|
2014
Q3 | $257K | Buy |
+9,150
| New | +$257K | 0.22% | 39 |
|
|
2014
Q2 | – | Sell |
-16,681
| Closed | -$508K | – | 46 |
|
|
2014
Q1 | $508K | Buy |
16,681
+2,492
| +18% | +$74.3K | 0.48% | 30 |
|
|
2013
Q4 | $412K | Buy |
+14,189
| New | +$413K | 0.4% | 33 |
|
Other funds holding PFE
Rench Wealth Management's PFE Position: Q1 2024 in Review
Rench Wealth Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 88,034 shares — an estimated $2.53M sold.
Rench Wealth Management first reported a position in PFE in Q4 2013 and held it in 37 quarters. The position peaked at $7.27M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Rench Wealth Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Rench Wealth Management sold 88,034 Pfizer shares in Q1 2024, an estimated $2.53M.
- Rench Wealth Management first reported a position in Pfizer in Q4 2013 and held it in 37 quarters.
- Rench Wealth Management's Pfizer position peaked at $7.27M in Q4 2021.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Rench Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.